Editing Guidelines: DEGRO Guidelines (Germany)

{{forproviders}}  {{forpolicymakers}}
Go back to [[Germany]] page

'''Primary purpose:''' To establish evidence-based practices for the use of stereotactic radiotherapy and radiosurgery.

'''Sponsor, manager or home institution:''' [[dataOwner::DEGRO]].

'''Type of information:''' Detailed protocols and evidence-based recommendations for conducting stereotactic radiotherapy and radiosurgery, focusing on specific conditions like brain metastases, early-stage non-small cell lung cancer (NSCLC), primary and secondary liver cancer, renal and pancreatic cancer, and ventricular tachycardia. These include best practices for treatment planning, dosing, patient selection, and outcomes assessment. [[availableVariable::medical procedures]]; [[availableVariable::diagnosis]]. [https://www.degro.org/ag-stereotaxie/projekte/practice-guidelines-of-the-degro-working-group-stereotactic-radiotherapy-radiosurgery/ Click here to learn more].

'''Cancer areas of interest:''' [[hasCancerType::C15-C26: Digestive system cancers]]; [[hasCancerType::C30-C39: Lung/chest cancers]]; [[hasCancerType::C69-C72: Eye and brain cancer]]; [[hasCancerType::C64-C68: Urinary system cancers]]; [[hasCancerType::C76-C80: Cancers of unknown or unspecified areas]]. [https://www.degro.org/ag-stereotaxie/projekte/practice-guidelines-of-the-degro-working-group-stereotactic-radiotherapy-radiosurgery/ Click here to learn more].

'''Access to information:''' [https://www.degro.org/ag-stereotaxie/projekte/practice-guidelines-of-the-degro-working-group-stereotactic-radiotherapy-radiosurgery/ Click here to access].